Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices.

Mayer A, Szasz BK, Kiss JP.

Neurochem Int. 2009 Nov;55(6):383-8. doi: 10.1016/j.neuint.2009.04.005.

PMID:
19393275
2.

The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters.

Nankai M, Klarica M, Fage D, Carter C.

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Jan;22(1):35-64. Review.

PMID:
9533166
3.
5.

Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?

Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V.

Curr Med Chem. 1999 Jun;6(6):469-80. Review.

PMID:
10213794
6.

Discriminative stimulus properties of antidepressant agents: a review.

Dekeyne A, Millan MJ.

Behav Pharmacol. 2003 Sep;14(5-6):391-407. Review.

PMID:
14501253
8.

[Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants].

Pacher P, Kecskeméti V.

Orv Hetil. 2004 Feb 22;145(8):425-31. Review. Hungarian.

PMID:
15061027
9.

Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.

Pacher P, Ungvari Z, Kecskemeti V, Furst S.

Curr Med Chem. 1998 Oct;5(5):381-90. Review.

PMID:
9756980
11.

Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems.

Joca SR, Ferreira FR, Guimarães FS.

Stress. 2007 Aug;10(3):227-49. Review.

PMID:
17613938
12.
13.

The neuropharmacology of serotonin and noradrenaline in depression.

Nutt DJ.

Int Clin Psychopharmacol. 2002 Jun;17 Suppl 1:S1-12. Review.

PMID:
12369606
14.

Does conventional anti-bipolar and antidepressant drug therapy reduce NMDA-mediated neuronal excitation by downregulating astrocytic GluK2 function?

Peng L, Li B, Du T, Wang F, Hertz L.

Pharmacol Biochem Behav. 2012 Feb;100(4):712-25. doi: 10.1016/j.pbb.2011.03.021. Review.

PMID:
21463649
15.

Triple uptake inhibitors: therapeutic potential in depression and beyond.

Chen Z, Skolnick P.

Expert Opin Investig Drugs. 2007 Sep;16(9):1365-77. Review.

PMID:
17714023
16.

Effects of antidepressants on uptake and receptor systems in the brain.

Fuller RW, Wong DT.

Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):485-90. Review.

PMID:
2868490
17.

Glutamate-based antidepressants: 20 years on.

Skolnick P, Popik P, Trullas R.

Trends Pharmacol Sci. 2009 Nov;30(11):563-9. doi: 10.1016/j.tips.2009.09.002. Review.

PMID:
19837463
18.

[Antagonists of ionotropic glutamate receptors as the object of research in psychopharmacology].

Bespalov AIu, Evartau EE.

Usp Fiziol Nauk. 1999 Jan-Mar;30(1):39-53. Review. Russian.

PMID:
10205818
19.

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.

Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R.

Pharmacopsychiatry. 1996 Jan;29(1):23-6. Review.

PMID:
8852530
20.

Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species.

Stone TW, Behan WM, MacDonald M, Darlington LG.

Amino Acids. 2000;19(1):275-81. Review.

PMID:
11026499

Supplemental Content

Support Center